Blood Test Foresees Decline into Alzheimer’s Disease
Researchers have identified a blood-based biomarker, p-tau217, that can predict the risk of Alzheimer's disease years before symptoms appear. The study suggests this could enable earlier intervention and better clinical trial design.
Why it matters
This discovery represents a significant advancement in early diagnostics for neurodegenerative diseases, potentially transforming patient care.
A blood-based biomarker could predict a person’s risk of developing Alzheimer’s disease years before any symptoms arise, research suggests.
The article reports on scientific research findings without political or social bias.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in